Gliclazid-Mepha 30 retard, Depotabs - 20 Tablette(n) Swissmedic Key 58504001 Registration Holder Mepha Pharma AG Name Gliclazid-Mepha 30 retard, Depotabs Date of registration 08.07.2008 Introduction of Sequence 08.07.2008 ATC-Classification Gliclazide (A10BB09) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.06.20. Show package size 20 Tablette(n) Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price 2.61 Deductible k.A. Consumer price 7.10 Feedback FB Daily cost GTIN 7680585040016 Medication Code Synthetika Pharmacode Disponibility
Composition gliclazidum 30.00 mg, hypromellosum, calcii carbonas, lactosum monohydricum 73.50 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Gliclazide 30 mg
BAG: Active Agent Dose Gliclazide 30 mg
Inactive agents Dose Calcium Carbonate Hypromellosum Lactose Monohydrate 73.5 mg Magnesii Stearas Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 04.11.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
